Skip to content
Search

Latest Stories

Pharmacy closure Skyrockets:177 businesses closed this year, warns NPA

Pharmacy closure Skyrockets:177 businesses closed this year, warns NPA

Rising costs and declining real terms funding led to the fastest rate of pharmacy closures in decades

The UK has witnessed a nearly 50 percent increase in pharmacy closures this year compared to the same period in 2023, which was already considered the worst year in recent memory.

A new analysis by the National Pharmacy Association (NPA) revealed that 177 pharmacies closed their doors between January and April 2024, compared to 116 in the same period last year. This is the equivalent of 10 local pharmacies shutting down every week.


Analysis of NHS figures by the NPA showed that 403 pharmacies closed their doors last year, nearly five times higher than the number that closed in 2022.  Since 2017, over 1,400 pharmacies have shut down across the UK.

Rising costs and declining real terms funding have led to the fastest rate of closures in decades, said the NPA, highlighting that “real terms funding has decreased by 40 per cent over the last decade.”

The association, which represents independent community pharmacies in the UK, has warned that many pharmacies are “running out of options to stay afloat” and permanent closures may be inevitable without an increase in funding in real terms.

It has urged the government to provide a new deal for pharmacies that “fills growing funding gaps, stabilises the network and stops the closures.”

This includes reversing historic cuts to pharmacy funding, advocating for community pharmacies to receive 2.5 per cent of the NHS budget, an increase from the current 1.6 per cent allocation.

NPA Chief Executive Paul Rees said: “These latest figures, which are skyrocketing, are absolutely shocking and distressing.

“Community pharmacies face a perfect storm of rapidly declining levels of real terms government funding and high levels of inflation – which is both increasing the cost of dispensing medicine and pushing many community pharmacies to the brink.

“Government funding no longer covers the costs of the nation’s medicines, leaving pharmacies to subsidise the NHS from their own pockets.

“Without a real-term increase in funding, pharmacies are being left with the choice of closing their doors or drastically reducing the service they can offer their local communities, making it more difficult for millions of people to get advice and vital medication.

“We need a new deal that delivers fair funding and provides an end to the mass closure of community pharmacies.”

Policy reversal needed to avert catastrophic impact

Janet Morrison, CEO of Community Pharmacy England (CPE), noted that the NPA's analysis provided further evidence confirming the stark reality that “many pharmacy businesses are on the brink of collapse.”

“Years of financial and operational pressures are continuing to take their toll as the government and NHS financial squeeze on the sector is now pushing all community pharmacies to the edge.

Pharmacies up and down the country are being forced to take drastic action, such as closing temporarily, cutting opening hours, reviewing their estates, and, if they can, closing branches.”

She warned that if the government and the NHS did not reverse this policy quickly, the impact would be catastrophic and vital healthcare services would become ever more chaotic, with medicines supply at great risk.

Janet added that the £645m recovery plan funding is “not enough” to reverse all of the pressures on community pharmacies, emphasising the urgent need for increased and sustained support and investment from the government and NHS.

According to her, the viability of pharmacy businesses remains CPE’s critical concern in funding discussions with policymakers.

 

 

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less